rTMS + Facet Joint Injections for Chronic Back Pain

Recruiting at 1 trial location

Overseen By Keaton Lightfoot, BSc

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: London Health Sciences Centre Research Institute and Lawson Research Institute of St. Joseph's

Must be taking: Steroid injections

Disqualifiers: Serious spinal pathology, Spinal surgery, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: 11

40 Participants Needed

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores whether combining a brain stimulation technique called repetitive transcranial magnetic stimulation (rTMS) with steroid joint injections, specifically Facet Joint Injections, can provide longer-lasting pain relief for people with chronic spinal pain. Steroid joint injections are commonly used but often require frequent repetition. Researchers aim to determine if rTMS can extend their effectiveness. Candidates should already receive regular steroid joint injections for chronic spinal pain and maintain consistent pain levels and medication use. As an unphased trial, participants can contribute to pioneering research that may enhance pain management strategies.

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications. However, it requires that you have had a consistent medication regimen for the past 3 months, which suggests you may need to continue your current medications.

Is there any evidence suggesting that this trial's treatments are likely to be safe?

Research has shown that repetitive transcranial magnetic stimulation (rTMS) is generally safe for most people, including those with brain conditions. Studies have found that rTMS can be safely used when safety guidelines are followed, even for individuals taking brain-affecting medications. Although limited research exists specifically on chronic spinal pain, many studies have reported significant pain relief with rTMS.

Steroid joint injections (SJI) are a common treatment for chronic back pain. However, their effects are short-lived, often necessitating repeated injections.

In summary, both rTMS and SJI have been studied separately and are considered safe when used properly. However, using them together in this trial is new, and the safety of this combination remains under investigation. ^{1 2 3 4 5}

Why are researchers excited about this trial?

Researchers are excited about this treatment for chronic back pain because it combines two powerful methods: repetitive transcranial magnetic stimulation (rTMS) and facet joint injections. Unlike standard treatments that often rely on medications or physical therapy, rTMS uses magnetic fields to stimulate nerve cells in the brain, potentially altering pain perception. This innovative approach, coupled with the localized relief from facet joint injections, might provide a more comprehensive pain management solution. This trial aims to reveal if this combination can offer faster, more effective relief than traditional methods.

What evidence suggests that this trial's treatments could be effective for chronic back pain?

Research shows that repetitive transcranial magnetic stimulation (rTMS) might help ease chronic back pain. In this trial, participants will receive either active rTMS or sham rTMS, both combined with steroid joint injections. Studies suggest that rTMS can lessen pain when used in various ways. This treatment uses magnetic fields to stimulate brain nerve cells, potentially altering pain perception. Although specific data on rTMS for chronic spinal pain is limited, it has shown promise for other long-term pain issues. Combining rTMS with steroid joint injections might enhance and prolong the pain relief from the injections. ^{4 6 7 8 9}

Who Is on the Research Team?

Siobhan Schabrun

Principal Investigator

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Are You a Good Fit for This Trial?

This trial is for individuals at St. Joseph's Health Centre in London, Ontario with chronic spinal pain who've had at least two facet joint injections in the past year and are experiencing significant pain despite treatment. Participants must have been on a stable medication regimen for three months and be able to understand English to give consent.

Inclusion Criteria

Had a consistent medication regimen for the past 3 months

I have had spinal pain of moderate intensity before my last steroid injection.

I have had 2 steroid injections in my joints in the last year.

Exclusion Criteria

History of uncontrolled mental health condition(s)

I do not have serious spine problems like tumors or fractures.

I had spinal surgery within the last year.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Induction Treatment

Participants receive active or sham rTMS 3 times each week for 2 weeks to enhance the effects of SJI

2 weeks

6 visits (in-person)

Maintenance Treatment

Participants receive a single active or sham rTMS session in weeks 3, 4, 6, 8, and 12

10 weeks

5 visits (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment

12 weeks

Weekly assessments (virtual)

What Are the Treatments Tested in This Trial?

Interventions

• Facet Joint Injection
• repetitive transcranial magnetic stimulation
• rTMS
• sham repetitive transcranial magnetic stimulation

Trial Overview The study tests if combining repetitive transcranial magnetic stimulation (rTMS) with routine facet joint injections (FJI) provides better, longer-lasting relief from chronic spinal pain than FJI alone. It also examines how this combination affects inflammation-related proteins that might influence chronic pain.

How Is the Trial Designed?

Group I: active repetitive transcranial magnetic stimulation + steroid joint injection Active Control 1 Intervention

Active transcranial stimulation will be delivered for a total of 11 sessions. Each session will consist of 40 trains of 5s delivered at 10 Hz, at an intensity of 85% of the resting motor threshold for the first dorsal interosseous muscle and an intertrain interval of 25s (total of 2000 stimulations in a 20-minute session).

Group II: sham repetitive transcranial magnetic stimulation + steroid joint injection Placebo Group 1 Intervention

The sham repetitive transcranial magnetic stimulation coil will be delivered using a Placebo D70mm Air Film Coil of identical colour, size, and shape as the active rTMS coil. The sham coil uses a magnetic shield that blocks the magnetic field from being delivered to the scalp while producing a similar auditory click during discharge. All other aspects of the rTMS protocol will be identical between the active and sham conditions.

Who Is Running the Clinical Trial?

London Health Sciences Centre Research Institute and Lawson Research Institute of St. Joseph's

Lead Sponsor

Trials

686

Recruited

427,000+

London Health Sciences Centre OR Lawson Research Institute of St. Joseph's

Lead Sponsor

Trials

668

Recruited

424,000+

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Lead Sponsor

Trials

678

Recruited

421,000+

Lawson Health Research Institute

Lead Sponsor

Trials

684

Recruited

432,000+

St. Joseph's Health Care London

Collaborator

Trials

28

Recruited

2,500+

Western University, Canada

Collaborator

Trials

270

Recruited

62,500+

Published Research Related to This Trial

In a study involving 90 patients with Fibromyalgia Syndrome, real low-frequency rTMS applied to the right dorsolateral prefrontal cortex significantly reduced pain and associated symptoms, with effects lasting up to 6 months after treatment.

The sham-rTMS group showed no significant changes, indicating that the benefits of rTMS are likely due to its mechanism of action on spinal pain circuits and top-down modulation of pain.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Repetitive transcranial magnetic stimulation of the prefrontal cortex for fibromyalgia syndrome: a randomised controlled trial with 6-months follow up. Tanwar, S., Mattoo, B., Kumar, U., et al.[2021]

In a study involving 17 patients with spinal cord injury and chronic neuropathic pain, repetitive transcranial magnetic stimulation (rTMS) did not show a significant advantage over sham treatment in reducing pain levels, indicating that its analgesic effect may not be superior to placebo.

Despite the lack of significant difference compared to sham treatment, rTMS did provide encouraging pain relief at 10 days and 6 weeks post-treatment, suggesting potential for further research with larger sample sizes to explore its efficacy.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

The effect of repetitive transcranial magnetic stimulation on refractory neuropathic pain in spinal cord injury. Yılmaz, B., Kesikburun, S., Yaşar, E., et al.[2021]

MRI-guided lumbar facet joint radiofrequency denervation (FRD) was performed successfully on 17 patients with chronic low back pain, showing no major complications and significant pain reduction over time.

Patients experienced a notable decrease in pain scores from a median of 8 before the procedure to 1 after 6 months, along with an increase in multifidus muscle volume, indicating both safety and efficacy of the treatment.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

MR-guided lumbar facet radiofrequency denervation for treatment of patients with chronic low back pain in an open 1.0 Tesla MRI system. Böning, G., Hartwig, T., Freyhardt, P., et al.[2022]

A 1-week treatment with repetitive transcranial magnetic stimulation (rTMS) significantly reduced pain levels in patients with chronic low back pain, as measured by the visual analogue scale (VAS) and Short Form McGill pain questionnaire (SF-MPQ).

Patients receiving rTMS experienced greater pain relief compared to those undergoing physical therapy, and the treatment was found to be safe with no evident side effects, indicating its potential as an effective long-term pain management option.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Analgesic effect of repetitive transcranial magnetic stimulation (rTMS) in patients with chronic low back pain. Ambriz-Tututi, M., Alvarado-Reynoso, B., Drucker-Colín, R.[2019]

Facet joint infiltrations provided significant pain relief for 81.8% of patients just 1 hour after the procedure, with sustained relief observed in 62.5% of patients even after 24 weeks, indicating its efficacy for chronic nonradicular low back pain.

The procedure was performed safely with no major complications reported, highlighting its status as a simple and minimally invasive treatment option for selected patients with chronic low back pain.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Image-guided lumbar facet joint infiltration in nonradicular low back pain. Chaturvedi, A., Chaturvedi, S., Sivasankar, R.[2022]

In a pilot study of 15 patients with chronic low back pain, hylan G-F 20 injections showed significant improvements in pain and disability measures up to 6 months, but these benefits were not sustained at 12 months.

While patient satisfaction increased shortly after treatment, it declined over time, and analgesic usage decreased significantly at 6 months but slightly increased again by 12 months, indicating modest and temporary efficacy of the treatment.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Prospective pilot study of painful lumbar facet joint arthropathy after intra-articular injection of hylan G-F 20. DePalma, MJ., Ketchum, JM., Queler, ED., et al.[2022]

Facet joint injections, commonly used to treat chronic low back pain, can lead to serious complications, including a rare case of subdural empyema and meningitis, as seen in a 47-year-old female patient.

This case emphasizes the importance of medical practitioners being vigilant about potential infectious complications following what is generally considered a safe procedure.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Subdural empyema following lumbar facet joint injection: An exceeding rare complication. Fayeye, O., Silva, AH., Chavda, S., et al.[2016]

The study involved 166 facet joint blocks performed on 45 patients with lower back pain, demonstrating that MRI-guided injections were technically successful with no major complications reported.

Patients experienced significant pain relief, with a reduction in the visual analogue scale (VAS) score from 7.1 at baseline to 3.5 after one week, indicating that the therapy is both effective and safe for treating lower back pain.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

MR-guided facet joint injection therapy using an open 1.0-T MRI system: an outcome study. Freyhardt, P., Hartwig, T., De Bucourt, M., et al.[2022]

Ultrasound-guided facet joint injections are feasible and effective for treating chronic low back pain, with 90% of patients showing clear visibility of the facet joints and successful injections.

This method significantly reduces procedure time (average of 14.3 minutes) and radiation exposure (14.2 mGy.cm) compared to CT-guided injections, which took longer (22.3 minutes) and involved much higher radiation doses (364.4 mGy.cm).

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Ultrasound-guided versus computed tomography-controlled facet joint injections in the lumbar spine: a prospective randomized clinical trial. Galiano, K., Obwegeser, AA., Walch, C., et al.[2019]

Repetitive transcranial magnetic stimulation (rTMS) is a noninvasive treatment that can provide partial and temporary relief from severe chronic pain, particularly in conditions like neuropathic pain and fibromyalgia.

While rTMS effects are generally short-lived, daily sessions over several weeks can lead to longer-lasting pain relief, and for patients who respond but later relapse, surgical options like implanted electrodes may help maintain the benefits.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Use of repetitive transcranial magnetic stimulation in pain relief. Lefaucheur, JP.[2022]

In a study of nine patients with thoracic facet disease, bipolar radiofrequency thermocoagulation resulted in a significant 47.6% reduction in pain, as measured by the Visual Analog Scale (VAS), one month after the procedure.

The treatment was found to be safe, with no serious complications reported, suggesting it could be a viable option for managing mid back pain originating from thoracic facet joints.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Bipolar Intra-articular Radiofrequency Thermocoagulation of the Thoracic Facet Joints: A Case Series of a New Technique. Kim, D.[2021]

Regenerative injection therapy (RIT) showed significant improvements in pain and functional outcomes for fibromyalgia patients compared to repetitive transcranial magnetic stimulation (rTMS), with benefits observed immediately after treatment and one month later.

While RIT was more effective for pain relief and functional improvement, rTMS demonstrated better results in reducing depression symptoms and enhancing cortical auditory evoked potentials, suggesting that a combination of both therapies could optimize treatment outcomes.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Regenerative injection therapy and repetitive transcranial magnetic stimulation in primary fibromyalgia treatment: A comparative study. Abd Elghany, SE., Al Ashkar, DS., El-Barbary, AM., et al.[2019]

In a study of 109 patients with chronic unilateral low-back pain, the type of injection (cortisone with local anesthetic vs. saline) did not significantly affect treatment outcomes, suggesting that the injection method may not be as critical as previously thought.

The best predictor of a positive treatment outcome was the presence of inappropriate signs (IAS) before injections, indicating that a patient's psychological and social factors play a crucial role in their recovery from low-back pain.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Chronic unilateral low-back pain. Predictors of outcome of facet joint injections. Lilius, G., Harilainen, A., Laasonen, EM., et al.[2022]

Radiofrequency denervation (RFD) significantly improves pain, reduces the need for analgesics, and enhances patient satisfaction in individuals with chronic low back pain from facet joint issues, based on a study of 44 patients over 2 years.

The benefits of RFD peak at 3 to 6 months post-procedure, with no reported complications, indicating it is a safe and effective short-term treatment option for this type of pain.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

A prospective outcome study on the effects of facet joint radiofrequency denervation on pain, analgesic intake, disability, satisfaction, cost, and employment. Burnham, RS., Holitski, S., Dinu, I.[2009]

In a study of 27 patients with failed back surgery syndrome, ultrasound-guided facet joint injections significantly reduced pain levels over six months, with a notable decrease in pain rating scores from 7.0 to 6.0 (p=0.006).

The injections also led to a significant improvement in lumbar flexion, increasing from 50.0° at baseline to 70.0° by the sixth month (p<0.001), indicating enhanced mobility without any reported complications.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Does ultrasound-guided facet joint injection reduce pain and improve mobility in patients with failed back surgery syndrome? Çırak, M., Çağlar Okur, S.[2021]

Citations

1. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov/articles/PMC10198434/

Transcranial magnetic stimulation for the treatment of ... The studies reviewed suggest the potential benefit in chronic lower back pain symptoms after various rTMS protocols and sites of stimulation.

2. brainstimjrnl.com brainstimjrnl.com/article/S1935-861X(14)00254-X/fulltext

Deep Repetitive Transcranial Magnetic Stimulation (dTMS) ... dTMS over the motor cortex with the sagittal HMCCPN coil has been successfully used to reduce symptoms in patients with diabetic neuropathic foot pain.

3. painphysicianjournal.com painphysicianjournal.com/current/pdf?article=NzE4OQ%3D%3D&journal=132

Effectiveness of Repetitive Transcranial Magnetic ... The success rate in low back surgery is variable; failure has been reported in 20% to 40% cases (2). Despite successful disc surgery, a number of patients with ...

4. clinicaltrials.gov clinicaltrials.gov/study/NCT03973788

Effects of Repetitive Transcranial Magnetic Stimulation on ... Effects of Repetitive Transcranial Magnetic Stimulation on Pain Thresholds in Patients With Chronic Low Back Pain. ClinicalTrials.gov ID NCT03973788. Sponsor ...

5. sciencedirect.com sciencedirect.com/science/article/abs/pii/S1094715924007189

ID: 328426 Repetitive Transcranial Magnetic Stimulation ... rTMS can produce analgesic effects in patients with chronic pain syndromes. Our goal is to review the literature to assess the effectiveness of rTMS for the ...

6. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov/articles/PMC12421619/

Dosage and safety of transcranial magnetic stimulation and ... Additionally, safety profiles for these non-invasive brain stimulation interventions in patients with CMP remain insufficiently reported, with ...

7. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov/articles/PMC9879417/

Safety Review for Clinical Application of Repetitive ... rTMS conforming to the current safety guidelines (Tables 3, 4, 5) can be applied safely to both healthy volunteers and patients with acquired brain diseases ...

8. sciencedirect.com sciencedirect.com/science/article/pii/S1388245720305149

Safety and recommendations for TMS use in healthy ... It has become apparent that such a risk is low, even in patients taking drugs acting on the central nervous system, at least with the use of traditional ...

9. archives-pmr.org archives-pmr.org/article/S0003-9993(14)01273-8/fulltext

Repetitive Transcranial Magnetic Stimulation in Chronic Pain A total of 33 randomized trials were found. Many studies reported significant pain relief by rTMS, especially high-frequency stimulation over the primary ...